AGC Inc plans to open a new R & D facility to increase synthetic pharmaceutical production base in Spain.
The new R & D facility is expected to start its operation in March 2021, while the expanded facility will come into existence in May 2022. In addition, the initiative will not only establish new R & D facility but also improve existing production facilities to achieve 1.3 times the capacity of the current production level.
This brand-new R&D center enables the development of processes from lab scale to commercial production, to deliver better and quick services to customers.
In addition, new micronisation facility is also planned to meet the rising demand for micronisation of active pharmaceutical ingredients.
AGC will continue to provide customers in each region with globally consistent, top-level quality and service in the life sciences sector.
AGC will enhance its technology and continue to pursue its goal by maximising synergies among operation sites.
|Completion Of Year